Reut Hod Dvorai

HLA Lab Director / Assistant Professor

SUNY Upstate Medical University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Reut Hod Dvorai is an Assistant Professor and HLA Lab Director at SUNY Upstate Medical University in the United States. Her research primarily focuses on clinical histocompatibility, kidney transplantation, and immunosuppression strategies. Recent publications reflect her expertise in personnel competency assessment, inter-laboratory variability in testing, and novel diagnostic approaches for transplant rejection.

Articles (18)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (7)

Anat R. Tambur

UNITED STATES

View details

Michael G. Ison

UNITED STATES

View details

Aneesha Shetty

Rush University Medical Center

UNITED STATES

View details

Rauf Shahbazov

UNITED STATES

View details

Matthew Cusick

HLA Director/ Assistant Professor

University of Michigan

UNITED STATES

View details

Brian Gallay

UNITED STATES

View details

Nicholas Brown

Associate Professor

University of Pennsylvania

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Reut Hod Dvorai

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Practical guide to personnel competency assessment in clinical histocompatibility laboratories.

Assessment of Inter-Laboratory Variability for Flow Cytometric Crossmatch Testing: Lessons Learned from Proficiency Surveys

Successful Treatment of Plasma Cell-Rich Acute Rejection Using Bortezomib: A Case Report.

Application of Combined Donor-Derived Cell-Free DNA and Transcriptome in Diagnosis of Kidney Transplant Rejection.

Belatacept based immunosuppression: What and when to combine?

Discrepancy Analysis between Histology and Molecular Diagnoses in Kidney Allograft Biopsies: A Single-Center Experience

Laparoscopic to robotic living donor nephrectomy: Is it time to change surgical technique?

Immunosuppression regimen modification during COVID-19 infection in kidney transplant recipients.

Early conversion to belatacept-based immunosuppression regimen promotes improved long-term renal graft function in kidney transplant recipients.

Deceased Donor Kidney Transplantation From Donors With Acute Kidney Injury: Realities and Costs.

Development of de novo donor‐specific antibodies in renal transplant recipients with BK viremia managed with immunosuppression reduction

Is Salvage of a Kidney Graft Possible as a Result of Hyperacute Rejection Immediately After Kidney Transplantation?

The Role of the Duffy Blood Group Antigens in Renal Transplantation and Rejection. A Mini Review.

Utilizing proficiency testing survey data to create advanced educational content: the virtual crossmatch challenge model.

Conversion to Belatacept in kidney transplant recipients with chronic antibody-mediated rejection (CAMR).

Identification of a DRB104:07–DRB401:03:01:02N haplotype in a native American individual

Tools for optimizing risk assessment in hematopoietic cell transplant - What can we get away with?

Impact of SIRPα polymorphism on transplant outcomes in HLA-identical living donor kidney transplantation.

Collaborators (7)

Anat R. Tambur

Michael G. Ison

Aneesha Shetty

Rauf Shahbazov

Matthew Cusick

Brian Gallay

Nicholas Brown

Make your next move.

Reut Hod Dvorai

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Practical guide to personnel competency assessment in clinical histocompatibility laboratories.

Assessment of Inter-Laboratory Variability for Flow Cytometric Crossmatch Testing: Lessons Learned from Proficiency Surveys

Successful Treatment of Plasma Cell-Rich Acute Rejection Using Bortezomib: A Case Report.

Application of Combined Donor-Derived Cell-Free DNA and Transcriptome in Diagnosis of Kidney Transplant Rejection.

Belatacept based immunosuppression: What and when to combine?

Discrepancy Analysis between Histology and Molecular Diagnoses in Kidney Allograft Biopsies: A Single-Center Experience

Laparoscopic to robotic living donor nephrectomy: Is it time to change surgical technique?

Immunosuppression regimen modification during COVID-19 infection in kidney transplant recipients.

Early conversion to belatacept-based immunosuppression regimen promotes improved long-term renal graft function in kidney transplant recipients.

Deceased Donor Kidney Transplantation From Donors With Acute Kidney Injury: Realities and Costs.

Development of de novo donor‐specific antibodies in renal transplant recipients with BK viremia managed with immunosuppression reduction

Is Salvage of a Kidney Graft Possible as a Result of Hyperacute Rejection Immediately After Kidney Transplantation?

The Role of the Duffy Blood Group Antigens in Renal Transplantation and Rejection. A Mini Review.

Utilizing proficiency testing survey data to create advanced educational content: the virtual crossmatch challenge model.

Conversion to Belatacept in kidney transplant recipients with chronic antibody-mediated rejection (CAMR).

Identification of a DRB1*04:07–DRB4*01:03:01:02N haplotype in a native American individual

Tools for optimizing risk assessment in hematopoietic cell transplant - What can we get away with?

Impact of SIRPα polymorphism on transplant outcomes in HLA-identical living donor kidney transplantation.

Collaborators (7)

Anat R. Tambur

Michael G. Ison

Aneesha Shetty

Rauf Shahbazov

Matthew Cusick

Brian Gallay

Nicholas Brown

Make your next move.

Identification of a DRB104:07–DRB401:03:01:02N haplotype in a native American individual